Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical validation of a non-invasive diagnostic test for adrenal insufficiency using comparative pharmacodynamic equivalence in a healthy population

Next Previous
Trial Profile

Clinical validation of a non-invasive diagnostic test for adrenal insufficiency using comparative pharmacodynamic equivalence in a healthy population

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 17 Sep 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Tetracosactide (Primary) ; Tetracosactide
  • Indications Adrenal insufficiency
  • Focus Diagnostic use
  • Acronyms STARLIT-2

Most Recent Events

  • 12 Sep 2024 Planned End Date changed from 28 Feb 2025 to 30 Sep 2025.
  • 09 Jul 2024 Recruitment completion is expected on 30 Sep 2024 , as per ISRCTN: Current Controlled Trials record.
  • 09 Jul 2024 Planned End Date changed from 30 Aug 2024 to 28 Feb 2025.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top